Ciglia Emanuele, Vergin Janina, Reimann Sven, Smits Sander H J, Schmitt Lutz, Groth Georg, Gohlke Holger
Institute for Pharmaceutical and Medicinal Chemistry, Heinrich-Heine-University, Düsseldorf, Germany.
Institute for Biochemical Plant Physiology, Heinrich-Heine-University, Düsseldorf, Germany.
PLoS One. 2014 Apr 23;9(4):e96031. doi: 10.1371/journal.pone.0096031. eCollection 2014.
Human heat shock protein of 90 kDa (hHsp90) is a homodimer that has an essential role in facilitating malignant transformation at the molecular level. Inhibiting hHsp90 function is a validated approach for treating different types of tumors. Inhibiting the dimerization of hHsp90 via its C-terminal domain (CTD) should provide a novel way to therapeutically interfere with hHsp90 function. Here, we predicted hot spot residues that cluster in the CTD dimerization interface by a structural decomposition of the effective energy of binding computed by the MM-GBSA approach and confirmed these predictions using in silico alanine scanning with DrugScore(PPI). Mutation of these residues to alanine caused a significant decrease in the melting temperature according to differential scanning fluorimetry experiments, indicating a reduced stability of the mutant hHsp90 complexes. Size exclusion chromatography and multi-angle light scattering studies demonstrate that the reduced stability of the mutant hHsp90 correlates with a lower complex stoichiometry due to the disruption of the dimerization interface. These results suggest that the identified hot spot residues can be used as a pharmacophoric template for identifying and designing small-molecule inhibitors of hHsp90 dimerization.
人类90 kDa热休克蛋白(hHsp90)是一种同型二聚体,在分子水平促进恶性转化中起关键作用。抑制hHsp90功能是治疗不同类型肿瘤的一种有效方法。通过其C末端结构域(CTD)抑制hHsp90的二聚化应为治疗性干扰hHsp90功能提供一种新方法。在此,我们通过MM - GBSA方法计算的结合有效能量的结构分解预测了聚集在CTD二聚化界面的热点残基,并使用DrugScore(PPI)的计算机丙氨酸扫描证实了这些预测。根据差示扫描荧光法实验,将这些残基突变为丙氨酸导致解链温度显著降低,表明突变型hHsp90复合物的稳定性降低。尺寸排阻色谱和多角度光散射研究表明,突变型hHsp90稳定性的降低与由于二聚化界面破坏导致的较低复合物化学计量比相关。这些结果表明,所鉴定的热点残基可作为药效团模板用于鉴定和设计hHsp90二聚化的小分子抑制剂。